OC
WVE icon

Oppenheimer & Co’s Wave Life Sciences WVE Stock Holding History

Oppenheimer & Co’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Buy
+49,122
New +$326K ﹤0.01% 1501

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Oppenheimer & Co's WVE Position: Q2 2026 in Review

Oppenheimer & Co opened a new position in Wave Life Sciences (WVE) in Q2 2026: 49,122 shares worth $285K. The stake represents ﹤0.01% of the portfolio and ranks #1501 among its holdings.

239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Oppenheimer & Co held 49,122 shares of Wave Life Sciences worth $285K as of Q2 2026.
  • Wave Life Sciences was a new Oppenheimer & Co position in Q2 2026.
  • Wave Life Sciences made up ﹤0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1501 holding.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.